Trial Profile
The Effect of Sugammadex on the Outcome After Colorectal Cancer Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2019
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 18 Aug 2019 Status changed from recruiting to completed.
- 17 Aug 2018 New trial record